Cantor Fitzgerald, L. P. Neuro Sense Therapeutics Ltd. Transaction History
Cantor Fitzgerald, L. P.
- $1.04 Billion
- Q3 2024
A detailed history of Cantor Fitzgerald, L. P. transactions in Neuro Sense Therapeutics Ltd. stock. As of the latest transaction made, Cantor Fitzgerald, L. P. holds 79,492 shares of NRSN stock, worth $103,339. This represents 0.01% of its overall portfolio holdings.
Number of Shares
79,492Holding current value
$103,339% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding NRSN
# of Institutions
8Shares Held
225KCall Options Held
0Put Options Held
0-
Xtx Topco LTD London, X046KShares$59,7940.0% of portfolio
-
Meitav Dash Investments LTD40KShares$52,0000.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il34.3KShares$44,5640.0% of portfolio
-
Commonwealth Equity Services, LLC12.6KShares$16,4120.0% of portfolio
-
Geode Capital Management, LLC Boston, MA12KShares$15,5510.0% of portfolio
About NeuroSense Therapeutics Ltd.
- Ticker NRSN
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,674,000
- Market Cap $15.2M